Authors:
Simon, R
Nocito, A
Hubscher, T
Bucher, C
Torhorst, J
Schraml, P
Bubendorf, L
Mihatsch, MM
Moch, H
Wilber, K
Schotzau, A
Kononen, J
Sauter, G
Citation: R. Simon et al., Patterns of HER-2/neu amplification and overexpression in primary and metastatic breast cancer, J NAT CANC, 93(15), 2001, pp. 1141-1146
Authors:
Bubendorf, L
Grilli, B
Sauter, G
Mihatsch, MJ
Gasser, TC
Dalquen, P
Citation: L. Bubendorf et al., Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings, AM J CLIN P, 116(1), 2001, pp. 79-86
Authors:
Mousses, S
Wagner, U
Chen, YD
Kim, JW
Bubendorf, L
Bittner, M
Pretlow, T
Elkahloun, AG
Trepel, JB
Kallioniemi, OP
Citation: S. Mousses et al., Failure of hormone therapy in prostate cancer involves systematic restoration of androgen responsive genes and activation of rapamycin sensitive signaling, ONCOGENE, 20(46), 2001, pp. 6718-6723
Authors:
Srivastava, M
Bubendorf, L
Nolan, L
Glasman, M
Leighton, X
Miller, G
Fehrle, W
Raffeld, M
Eidelman, O
Kallioniemi, OP
Srivastava, S
Pollard, HB
Citation: M. Srivastava et al., ANX7 as a bio-marker in prostate and breast cancer progression, DIS MARKER, 17(2), 2001, pp. 115-120
Authors:
El Gedaily, A
Bubendorf, L
Willi, N
Fu, W
Richter, J
Moch, H
Mihatsch, MJ
Sauter, G
Gasser, TC
Citation: A. El Gedaily et al., Discovery of new DNA amplification loci in prostate cancer by comparative genomic hybridization, PROSTATE, 46(3), 2001, pp. 184-190
Authors:
Srivastava, M
Bubendorf, L
Srikantan, V
Fossom, L
Nolan, L
Glasman, M
Leighton, X
Fehrle, W
Pittaluga, S
Raffeld, M
Koivisto, P
Willi, N
Gasser, TC
Kononen, J
Sauter, G
Kallioniemi, OP
Srivastava, S
Pollard, HB
Citation: M. Srivastava et al., ANX7, a candidate tumor suppressor gene for prostate cancer, P NAS US, 98(8), 2001, pp. 4575-4580
Citation: L. Bubendorf et al., Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies, J PATHOLOGY, 195(1), 2001, pp. 72-79
Authors:
Nocito, A
Bubendorf, L
Tinner, EM
Suess, K
Wagner, U
Forster, T
Kononen, J
Fijan, A
Bruderer, J
Schmid, U
Ackermann, D
Maurer, R
Alund, G
Knonagel, H
Rist, M
Anabitarte, M
Hering, F
Hardmeier, T
Schoenenberger, AJ
Flury, R
Jager, P
Fehr, JL
Schraml, P
Moch, H
Mihatsch, MJ
Gasser, T
Sauter, G
Citation: A. Nocito et al., Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade, J PATHOLOGY, 194(3), 2001, pp. 349-357
Authors:
Barlund, M
Forozan, F
Kononen, J
Bubendorf, L
Chen, YD
Bittner, ML
Torhorst, J
Haas, P
Bucher, C
Sauter, G
Kallioniemi, OP
Kallioniemi, A
Citation: M. Barlund et al., Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis, J NAT CANC, 92(15), 2000, pp. 1252-1259
Authors:
Fu, WT
Bubendorf, L
Willi, N
Moch, H
Mihatsch, MJ
Sauter, G
Gasser, TC
Citation: Wt. Fu et al., Genetic chances in clinically organ-confined prostate cancer by comparative genomic hybridization, UROLOGY, 56(5), 2000, pp. 880-885
Authors:
Bowen, C
Bubendorf, L
Voeller, HJ
Slack, R
Willi, N
Sauter, G
Gasser, TC
Koivisto, P
Lack, EE
Kononen, J
Kallioniemi, OP
Gelmann, EP
Citation: C. Bowen et al., Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression, CANCER RES, 60(21), 2000, pp. 6111-6115
Authors:
Bubendorf, L
Kolmer, M
Kononen, J
Koivisto, P
Mousses, S
Chen, YD
Mahlamaki, E
Schraml, P
Moch, H
Willi, N
Elkahloun, AG
Pretlow, TG
Gasser, TC
Mihatsch, MJ
Sauter, G
Kallioniemi, OP
Citation: L. Bubendorf et al., Hormone therapy failure in human prostate cancer: Analysis by complementary DNA and issue microarrays, J NAT CANC, 91(20), 1999, pp. 1758-1764
Authors:
Terracciano, L
Kocher, T
Cathomas, G
Bubendorf, L
Lehmann, FS
Citation: L. Terracciano et al., Langerhans cell histiocytosis of the stomach with atypical morphological features, PATHOL INT, 49(6), 1999, pp. 553-556
Authors:
Lee, SK
Anzick, SL
Choi, JE
Bubendorf, L
Guan, XY
Jung, YK
Kallioniemi, OP
Kononen, J
Trent, JM
Azorsa, D
Jhun, BH
Cheong, JH
Lee, YC
Meltzer, PS
Lee, JW
Citation: Sk. Lee et al., A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivatoressential for ligand-dependent transactivation by nuclear receptors in vivo, J BIOL CHEM, 274(48), 1999, pp. 34283-34293
Citation: L. Bubendorf, Survey of gene amplifications during prostate cancer progression by high throughput fluorescence in situ hybridization on tissue microarrays (vol 59,pg 803, 1999), CANCER RES, 59(6), 1999, pp. 1388-1388
Authors:
Bubendorf, L
Kononen, J
Koivisto, P
Schraml, P
Moch, H
Gasser, TC
Willi, N
Mihatsch, MJ
Sauter, G
Kallioniemi, OP
Citation: L. Bubendorf et al., Survey of gene amplifications during prostate cancer progression by high throughput fluorescence in situ hybridization on tissue microarrays, CANCER RES, 59(4), 1999, pp. 803-806
Authors:
Moch, H
Schraml, P
Bubendorf, L
Mirlacher, M
Kononen, J
Gasser, T
Mihatsch, MJ
Kallioniemi, OP
Sauter, G
Citation: H. Moch et al., High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma, AM J PATH, 154(4), 1999, pp. 981-986